NewsBite

Street Talk

Star Combo Pharma pitches chunky M&A deal, raising via Bell Potter

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Listed health foods and vitamins company Star Combo Pharma is in front of fund managers seeking support for a potentially company-changing M&A deal and equity raising.

Star Combo has agreed terms to acquire Melbourne-based Bio-E, which is a fast growing natural health, food and beverage company that's on track to make $15 million EBITDA in the 2019 financial year.

Loading...
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Anthony Macdonald is a Chanticleer columnist. He is a former Street Talk co-editor and has 10 years' experience as a business journalist and worked at PwC, auditing and advising financial services companies. Connect with Anthony on Twitter. Email Anthony at a.macdonald@afr.com

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Subscribe now

Already a subscriber?

Read More

Original URL: https://www.afr.com/street-talk/star-combo-pharma-pitches-chunky-m-and-a-deal-raising-via-bell-potter-20190704-p5240p